Role of Purinergic Signaling in Voiding Dysfunction. - Wikidata - awgldk - TriplyDB

Role of Purinergic Signaling in Voiding Dysfunction.

Role of Purinergic Signaling in Voiding Dysfunction.

http://www.wikidata.org/entity/Q34973917

about

Research Findings on Overactive Bladder Luminal DMSO: effects on detrusor and urothelial/lamina propria function.Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.Effect of type II diabetes on male rat bladder contractility.Bladder dysfunction in patients with diabetes.Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.Functional and molecular changes of the bladder in rats with crushing injury of nerve bundles from major pelvic ganglion to the bladder: role of RhoA/Rho kinase pathway Proteomic analysis of urothelium of rats with detrusor overactivity induced by bladder outlet obstruction.The aging bladder insights from animal models.

P2860

Q26801459-79E4FEAE-D1E5-4950-8B7A-954C7B31DB1B Q33736197-F1B9EC1C-E770-4BEC-A8D6-6F3ABCCC0649 Q36788773-B20FD33F-43F9-48DD-A16A-2F3258F247EC Q36902208-EA4FFA88-EC86-4210-B85C-D86E06EEED37 Q37926947-F8310C1C-8455-4620-8D18-ECB17231565F Q41520436-9338191A-E4D1-446A-8B09-F2058F8C8F70 Q42663748-69526BB8-8E55-4BA0-9A1A-8E5D3BEB39E9 Q48508163-BC921DF5-6236-4BE6-8A19-52E93371C5E4 Q55519777-6039D0B0-D148-4A5A-8175-0C127A0CC6FF

P2860

Role of Purinergic Signaling in Voiding Dysfunction.

http://www.wikidata.org/entity/Q34973917

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Role of Purinergic Signaling in Voiding Dysfunction.

@ast

Role of Purinergic Signaling in Voiding Dysfunction.

@en

Role of Purinergic Signaling in Voiding Dysfunction.

@nl

type

label

Role of Purinergic Signaling in Voiding Dysfunction.

@ast

Role of Purinergic Signaling in Voiding Dysfunction.

@en

Role of Purinergic Signaling in Voiding Dysfunction.

@nl

prefLabel

Role of Purinergic Signaling in Voiding Dysfunction.

@ast

Role of Purinergic Signaling in Voiding Dysfunction.

@en

Role of Purinergic Signaling in Voiding Dysfunction.

@nl

P1433

Q34973917-CC550EFC-E1C9-49BC-AC85-3513F535DF01

P1476

Q34973917-FA944355-A9E1-44FC-9F9C-E748ED9FD4FD

P2093

Q34973917-9F1774F2-8888-4821-9D59-3FAB8EACFA09

Q34973917-CAB2C83D-869A-41D7-AD16-A6EAF8C3BAE1

P2860

Q34973917-01A0B466-9FD8-40E3-AD1F-40A150970BDA

Q34973917-10F77BAD-2A3B-4901-BE78-41493218BC07

Q34973917-16F926B7-874E-4E75-BF71-B849C60BCC99

Q34973917-1D0BBD30-D24C-4ADC-9360-FADC7B49332C

Q34973917-201C232C-2DBC-4774-901E-335134191400

Q34973917-211EE2C4-A9EC-4BC0-82ED-6D124D903164

Q34973917-2A8339AD-C8E7-4026-B9C3-BCFF13213294

Q34973917-3DF3DB29-D5FE-4989-8C2A-8E5848A9529F

Q34973917-3F950BC1-71A4-4439-8B34-06788AAD5CBC

Q34973917-45DE4D06-06E4-41D2-BBCD-9588CC24453D

P2888

Q34973917-3926C243-DDDA-4069-A865-39B5998DEBD8

P304

Q34973917-89A3B353-8E3B-46D0-83FE-63A134157E42

P31

Q34973917-F88DFE13-8608-490C-8E40-5D3D99756886

P356

Q34973917-F6D7BEEB-4C92-4BAA-8BD9-C1EC5DF53D3D

P433

Q34973917-527B2FE9-36FD-4F4D-8520-73D39210EE14

P478

Q34973917-A90945EF-C30A-478B-8C6E-EA7E738955AC

P577

Q34973917-046ACEEF-A085-4215-9C04-802262075A4C

P5875

Q34973917-DF535103-2D7A-4B86-99FF-819F124375A9

P6179

Q34973917-7C93A585-582A-485A-B329-2E373F3B8A56

P698

Q34973917-70CBF9D0-E250-4673-AFC3-09B65531375D

P932

Q34973917-901919D8-EEF0-402B-9A96-161933D90EF8

P356

S11884-010-0063-6

P1433

Current bladder dysfunction reports

P1476

Role of Purinergic Signaling in Voiding Dysfunction.

@en

P2093

Toby C Chai

http://www.w3.org/2001/XMLSchema#string

Yan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury

P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles.

ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells

Changes in afferent activity after spinal cord injury.

P2X2 and P2X3 receptor expression in postnatal and adult rat urinary bladder and lumbosacral spinal cord.

Potential therapeutic targets in the rapidly expanding field of purinergic signalling.

Overactive bladder--pharmacological aspects.

Pharmacologic perspective on the physiology of the lower urinary tract.

P2888

s11884-010-0063-6

P304

219-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11884-010-0063-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51127064

http://www.w3.org/2001/XMLSchema#string

P6179

1042538797

http://www.w3.org/2001/XMLSchema#string

P698

21572572

http://www.w3.org/2001/XMLSchema#string

P932

3092392

http://www.w3.org/2001/XMLSchema#string